StocksMelrose Industries outlines Garden Grove restart and claims plan
Latest
HDFC Bank Shares Hit Fresh 52-Week Low Despite Legal Wins
HDFC Bank shares fell to a 52-week low of ₹681.90 on Friday, defying recent favorable court rulings in Bahrain that dismissed all seven Credit Suisse AT1 bond cases against the lender.
Unicycive Faces Class Action After FDA Rejection
Unicycive Therapeutics is under legal scrutiny following a 39% stock drop triggered by the FDA's rejection of its kidney disease drug resubmission.
FuelCell Energy Q3 Losses Spike on Fit Energy Deal
FuelCell Energy shares dropped 15.7% as a $24.5 million quarterly gross loss revealed that product costs for the Fit Energy contract exceed contractual pricing.
Cardinal Infrastructure Faces Inquiry After Q2 Margin Collapse
Cardinal Infrastructure Group's stock dropped 36% after Q2 results revealed sharp margin compression, prompting a securities investigation by Hagens Berman.
Columbia Gas Pays $875K Penalty For Pipeline Fusion Failures
Columbia Gas settled with the Pennsylvania PUC for $875,000 to resolve safety violations involving defective polyethylene pipe joints in western Pennsylvania.
Deutsche Bank Settles €152M Ex-Banker Claim
Deutsche Bank resolved a Frankfurt lawsuit for an undisclosed sum, citing minimal Q3 impact, while four former employees continue to pursue over £600 million in London.
Capricor Faces Fraud Suit Over Dermamiocel Data
Capricor Therapeutics is under investigation following a 64% single-day stock drop triggered by FDA disclosures regarding statistical analysis changes.
Hertz faces securities suit over liquidity disclosures
Hertz Global Holdings faces a class-action lawsuit alleging misleading liquidity statements preceded a 40% stock drop and a dilutive capital raise.
Wisconsin DNR Halts Enbridge Bypass Construction
Wisconsin regulators have ordered Enbridge to halt construction of its Line 5 temporary bypass, citing a lack of state approvals and ongoing environmental violations at the Iron County spill site. DNR Secretary Karen Hyun’s latest letter demands the company focus on remediating the massive gas leak, while environmental advocates criticize the firm for moving earth and crossing waterways without proper legal authorization.
NJ American Water Raises Rates to Fund Infrastructure
New Jersey American Water has secured regulatory approval for a rate hike that will raise average bills by approximately $8 per month, a figure composed of separate $4 increases for water and wastewater services. The company intends to use funds from federal PFAS contamination lawsuits to provide a temporary credit to ratepayers, helping to fund over $1 billion in infrastructure upgrades and compliance with federal chemical standards.
Federal court orders New Jersey to re-examine NESE pipeline permit
A Third-Circuit ruling forces New Jersey regulators to revisit the water-quality permit for the Northeast Supply Enhancement project, citing insufficient explanation of environmental impacts.
Kaplan Fox Investigates Alignment Healthcare Accounting Practices
Kaplan Fox is investigating Alignment Healthcare for securities law violations, with new details confirming that systematic misclassification of operating expenses inflated Adjusted EBITDA. This accounting irregularity, exposed by a whistleblower complaint, led to a sharp 16.7% decline in the company's share price on July 8, 2026.
More
Illustration: Tradingbird PROCEPT BioRobotics Faces Class Action Over Sales Tactics
Kaplan Fox & Kilsheimer LLP alleges PROCEPT BioRobotics artificially inflated revenue by pulling forward demand through undisclosed discounting.
Illustration: Tradingbird EquipmentShare Faces Class Action Over Alleged Founder Payments
EquipmentShare.Com Inc (NASDAQ: EQPT) is under legal scrutiny after a report alleged that related-party transactions netted founders at least $77 million, triggering a sharp drop in the company's stock price and a securities class action lawsuit.
Illustration: Tradingbird Blaize Holdings Faces Class Action Over Alleged Revenue Misreporting
Kaplan Fox & Kilsheimer LLP filed a securities class action against Blaize Holdings, alleging inflated growth metrics and improper revenue recognition between mid-2025 and early 2026.
Illustration: Tradingbird Beta Bionics Faces Class Action Over Insulin Pump Safety Allegations
Beta Bionics faces a securities class action alleging that the company concealed serious device malfunctions and FDA violations, leading to a significant stock decline after public disclosures in early 2026.
Illustration: Tradingbird EquipmentShare Faces Securities Suit Over Founder Transactions
EquipmentShare.Com Inc faces a class action alleging undisclosed related-party deals inflated its IPO price, triggering a 6.6% stock drop.
Illustration: Tradingbird Capricor Faces Securities Suit Over Dermamiocel Plan Changes
A class action alleges Capricor misled investors regarding its statistical analysis plan for Dermamiocel, leading to a 64% stock drop.
Illustration: Tradingbird Federal Court Vacates Permit for Williams Pipeline
A federal appeals court has voided a key environmental permit for Williams Cos.'s $1 billion Northeast Supply Enhancement project, citing procedural flaws in New Jersey's approval process.
Illustration: Tradingbird Third Circuit Vacates NJ Permit for Williams NESE Pipeline
The Third Circuit has vacated the New Jersey water permit for Williams' NESE pipeline, citing inadequate justification for dredging impacts, despite the company’s assertion that construction timelines remain on track for a late-2027 start. This decision contrasts with a recent Second Circuit ruling that upheld the equivalent New York permit, while environmental groups continue to challenge the project’s approvals across state lines.
Illustration: Tradingbird Whitmer demands Enbridge halt Line 5 operations over safety risks
Governor Whitmer has formally requested that Enbridge stop operating the 73-year-old Line 5 pipeline, arguing that the Michigan Supreme Court’s recent ruling has eliminated the legal basis for the proposed replacement tunnel.
Illustration: Tradingbird Blaize Faces Class Action Over Revenue Integrity Allegations
Blaize Holdings faces a securities class action alleging improper revenue recognition and inflated growth metrics, following a 12% stock drop after a short-seller report.
Illustration: Tradingbird Holmes Backer Raises $18M for New Blood Test Startup
Former Theranos CEO Elizabeth Holmes is advising a new $18 million blood-testing venture from prison, despite prominent investors declining to participate.